Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity

This study has been completed.
Ontario Neurotrauma Foundation
Information provided by (Responsible Party):
Magdy Hassouna, Toronto Rehabilitation Institute Identifier:
First received: December 1, 2008
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)